Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TTX | Ann: Removal from Official List | 16/07/10 | 0 | 393 | |||
|
|||||||
TTX | Ann: Distribution payment and 100 percent redempt | 30/06/10 | 0 | 228 | |||
|
|||||||
TTX | Ann: Amendment to the TAPS Constitution | 28/06/10 | 0 | 216 | |||
|
|||||||
TTX | Ann: Suspension from Official Quotation at close | 16/06/10 | 0 | 203 | |||
|
|||||||
TTX | Ann: Appointment of Company Secretary | 28/05/10 | 0 | 243 | |||
|
|||||||
TTX | Ann: Distribution letter for the quarter ended 31 | 13:43 | 0 | 247 | |||
|
|||||||
TTX | Ann: Redemption and distribution letter to invest | 16/04/10 | 0 | 121 | |||
|
|||||||
HDF +TTX | Ann: HDF to redeem and repay 100 percent of TAPS | 13/04/10 | 1 | 354 | |||
|
See All Discussions